ANNOUNCEMENT

Click here to download pdf brochure for MedCity CONVERGE, to be held July 9-10 in Philadelphia.

Topic: St. Jude Medical

Is St. Jude Medical’s battle against Optim supplier more than just a “headache?”

Is St. Jude Medical’s battle against Optim supplier more than just a “headache?”

October 19, 2012 12:30 pm by | 0 Comments

October has not been kind to St. Jude Medical (NYSE:STJ).On Wednesday, the company, apparently against all industry precedent, warned Wall Street of a possible warning letter from the U.S. Food ... Read more
St. Jude Medical does the unthinkable: Warns of FDA warning letter before FDA issues one

St. Jude Medical does the unthinkable: Warns of FDA warning letter before FDA issues one

October 17, 2012 9:52 am by | 5 Comments

Analyst Bob Hopkins of Bank of America was mystified and sounded a bit worried on the St. Jude Medical (NYSE:STJ) morning conference call to discuss the company’s third-quarter earnings Wednesday.St. ... Read more
St. Jude Medical’s newly launched technology aims to reduce radiation exposure

St. Jude Medical’s newly launched technology aims to reduce radiation exposure

October 8, 2012 4:02 pm by | 0 Comments

St. Jude Medical (NYSE:STJ) announced Monday that it has launched a new 3D navigation system to evaluate heart and vascular anatomy on recorded fluroscopy images instead of a series of ... Read more
EU approves world’s smallest, implanted rechargeable device to treat chronic migraine

EU approves world’s smallest, implanted rechargeable device to treat chronic migraine

September 20, 2012 5:33 pm by | 0 Comments

St. Jude Medical (NYSE:STJ) announced Thursday that the Minnesota medical device maker has received European regulatory approval to market the Eon Mini Neurostimulator, the world’s smallest, implanted rechargeable device to ... Read more
Analysts: St. Jude Medical layoffs likely a move to offset pressure of medical device tax

Analysts: St. Jude Medical layoffs likely a move to offset pressure of medical device tax

August 31, 2012 11:21 am by | 0 Comments

On Thursday, St. Jude Medical (NYSE:STJ) announced that it was laying off 300 people and organizing its four businesses under two operating units.The move, the Minnesota medical device maker stated, ... Read more
St. Jude Medical layoffs affect 300 as it centralizes functions, realigns into two units

St. Jude Medical layoffs affect 300 as it centralizes functions, realigns into two units

August 30, 2012 2:48 pm by | 0 Comments

St. Jude Medical (NYSE:STJ) announced Thursday that it is laying of 300 employees as part of a broader restructuring aimed to lower operating costs.In a news release, the Minnesota medical ... Read more
St. Jude Medical’s renal denervation system effective in lowering blood pressure

St. Jude Medical’s renal denervation system effective in lowering blood pressure

August 28, 2012 12:17 pm by | 0 Comments

St. Jude Medical (NYSE:STJ) announced Tuesday that its renal denervation technology was effective in lowering blood pressure of patients whose hypertension remained stubbornly high despite being on many medications.The EnligHTN ... Read more
Prominent cardiologist: Doctors should use MDT, BSX leads instead of St. Jude’s Durata

Prominent cardiologist: Doctors should use MDT, BSX leads instead of St. Jude’s Durata

August 21, 2012 12:43 pm by | 0 Comments

UPDATE: Scroll down to see St. Jude Medical’s detailed statement.Dr. Robert Hauser will not make the list of St. Jude Medical’s most favorite cardiologists any time soon.Hauser, a prominent cardiologist ... Read more
FDA’s new x-ray mandate for Riata patients doesn’t ignores complexities of reality

FDA’s new x-ray mandate for Riata patients doesn’t ignores complexities of reality

August 19, 2012 4:00 pm by | 0 Comments

If you have not already heard, there was more news (see theHeart.org) on the troubled St. Jude Medical Riata family of ICD leads. The high voltage leads were recalled in ... Read more
Barclays remains confident in St. Jude’s Medical and Durata leads

Barclays remains confident in St. Jude’s Medical and Durata leads

August 17, 2012 3:30 pm by | 0 Comments

Barclays released a report Friday maintaining its Overweight rating of St. Jude Medical (NYSE: STJ) and $48 PT. In the report, Barclays stated, "[While] we understand the concerns around Durata, ... Read more
Skeptical of Durata lead safety, FDA orders post-marketing surveillance study

Skeptical of Durata lead safety, FDA orders post-marketing surveillance study

August 16, 2012 3:55 pm by | 0 Comments

Looks like the Food and Drug Administration is not buying St. Jude Medical’s (NYSE:STJ) insistence that the Durata ICD lead is safe.While some have argued that the Durata leads are ... Read more
In Chick-fil-A gay marriage debate, St. Jude Medical, not medtech firm Vante, is the model

In Chick-fil-A gay marriage debate, St. Jude Medical, not medtech firm Vante, is the model

August 7, 2012 11:16 am by | 7 Comments

By now, many of you have heard the news that medical device manufacturer and supplier Vante fired its chief financial officer for berating a Chick-fil-A employee because she worked at ... Read more
FDA clears first “smart pill” that senses when it’s been taken, sends data to wearable patch

FDA clears first “smart pill” that senses when it’s been taken, sends data to wearable patch

July 30, 2012 3:21 pm by | 1 Comments

Behold, convergence.A startup backed by the likes of Medtronic and Novartis has combined sensors with mobile technology, pharmaceuticals and medical devices to develop what’s being hyped as the U.S.’s first ... Read more
Boston Scientific CEO as unsure about bottom of global CRM market as St. Jude

Boston Scientific CEO as unsure about bottom of global CRM market as St. Jude

July 26, 2012 10:05 am by | 0 Comments

If people are looking for confirmation that the global cardiac rhythm management market has declined as much as it could and will fall no further, they have to wait a ... Read more
St. Jude CEO on global CRM market: “We have not been able to predict the bottom”

St. Jude CEO on global CRM market: “We have not been able to predict the bottom”

July 19, 2012 3:46 pm by | 0 Comments

 St. Jude Medical (NYSE:STJ) may have performed better than expected in the cardiac rhythm management business in the second quarter, but that doesn’t necessarily mean the company is confident about ... Read more